未登录

V

Vera Battini

Università degli Studi di Milano

H指数:15

被引数:1,101

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-World Patterns of Delayed Cutaneous Adverse Reactions to Antimicrobial Therapy in Children: A Case Series and FAERS Analysis Across Age Groups

儿童抗菌治疗延迟性皮肤不良反应的实世界模式：不同年龄组的病例系列和FAERS分析

Antibiotics-Basel

IF4.6

2026-08-040

OA

Biomedical Large Language Models and Prompt Engineering for Causality Assessment of Individual Case Safety Reports in Pharmacovigilance

生物医学大语言模型及提示工程在药物警戒中个体病例安全性报告因果关系评估的应用

Pharmaceutical Research

IF4.3

2026-05-230

OAAI

Off-Label Ustekinumab and Vedolizumab in Pediatric Anti-TNFα Refractory IBD: Therapeutic Drug Monitoring Insights from a Case Series

超说明书适应证下的乌司奴单抗和 vedolizumab 在儿科抗-TNFα 难治性炎症性肠病中的应用：来自病例系列的治疗药物监测见解

Pharmaceuticals

IF4.8

2026-01-160

OAAI

Exploring the impact of GLP-1 analogues and DPP-4 inhibitors on cognitive decline in elderly patients with type 2 diabetes: a competing risks analysis from a real-world cohort

探索GLP-1类似物和DPP-4抑制剂对2型糖尿病老年患者认知衰退的影响：一项来自真实世界队列的竞争风险分析

Frontiers in Pharmacology

IF4.8

2026-01-010

OAAI

Olmesartan-Induced Enteropathy: Case Reports and Insights From FDA Adverse Event Reporting System (FAERS)

奥美沙坦诱导性肠病：病例报告及来自FDA不良事件报告系统（FAERS）的见解

JOURNAL OF PHARMACY PRACTICE

IF0

2025-09-010

PRE

Artificial intelligence in pharmacovigilance signal management: a review of tools, implementations, research, and regulatory landscape

人工智能在药物警戒信号管理中的应用：工具、实施、研究和监管环境的综述

Expert Opinion on Drug Safety

IF3.1

2025-08-130

PRE

NAT2 Acetylation Status Predicts Hepatotoxicity During Antituberculosis Therapy: Cumulative Risk Analysis of a Multiethnic Cohort

NAT2 乙酰化状态预测抗结核治疗期间的肝毒性：多民族队列的累积风险分析

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

IF4.9

2025-04-190

OA

Network Analysis and Machine Learning for Signal Detection and Prioritization Using Electronic Healthcare Records and Administrative Databases: A Proof of Concept in Drug-Induced Acute Myocardial Infarction

IF3.8

2025-02-070

OAAI

NAT2 Slow Acetylator Phenotype as a Significant Risk Factor for Hepatotoxicity Caused by Antituberculosis Drugs: Results From a Multiethnic Nested Case-Control Study

CLINICAL INFECTIOUS DISEASES

IF7.3

2024-12-271

PRE

Low-dose aspirin and risk of anaemia in older adults: insights from a Danish register-based cohort study

EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES

IF4.6

2024-10-110

PRE

The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement

IF3.8

2024-05-0735

OAAI

Fusaroli, Michele; Salvo, Francesco; Begaud, Bernard; Alshammari, Thamir M.; Bate, Andrew; Battini, Vera; Brueckner, Andreas; Candore, Gianmario; Carnovale, Carla; Crisafulli, Salvatore; Cutroneo, Paola Maria; Dolladille, Charles; Drici, Milou-Daniel; Faillie, Jean-Luc; Goldman, Adam; Hauben, Manfred; Herdeiro, Maria Teresa; Mahaux, Olivia; Manlik, Katrin; Montastruc, Francois; Noguchi, Yoshihiro; Noren, G. Niklas; Noseda, Roberta; Onakpoya, Igho J.; Pariente, Antoine; Poluzzi, Elisabetta; Salem, Myriam; Sartori, Daniele; Trinh, Nhung T. H.; Tuccori, Marco; van Hunsel, Florence; van Puijenbroek, Eugene; Raschi, Emanuel; Khouri, Charles

The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration

IF3.8

2024-05-0772

OAAI

Fusaroli, Michele; Salvo, Francesco; Begaud, Bernard; Alshammari, Thamir M.; Bate, Andrew; Battini, Vera; Brueckner, Andreas; Candore, Gianmario; Carnovale, Carla; Crisafulli, Salvatore; Cutroneo, Paola Maria; Dolladille, Charles; Drici, Milou-Daniel; Faillie, Jean-Luc; Goldman, Adam; Hauben, Manfred; Herdeiro, Maria Teresa; Mahaux, Olivia; Manlik, Katrin; Montastruc, Francois; Noguchi, Yoshihiro; Noren, G. Niklas; Noseda, Roberta; Onakpoya, Igho J.; Pariente, Antoine; Poluzzi, Elisabetta; Salem, Myriam; Sartori, Daniele; Trinh, Nhung T. H.; Tuccori, Marco; van Hunsel, Florence; van Puijenbroek, Eugene; Raschi, Emanuel; Khouri, Charles

Timing Matters: A Machine Learning Method for the Prioritization of Drug-Drug Interactions Through Signal Detection in the FDA Adverse Event Reporting System and Their Relationship with Time of Co-exposure

IF3.8

2024-04-302

OAAI

Exploring the impact of co-exposure timing on drug-drug interactions in signal detection through spontaneous reporting system databases: a scoping review

EXPERT REVIEW OF CLINICAL PHARMACOLOGY

IF3

2024-04-181

PRE

Evaluating the 6-month formulation of paliperidone palmitate: a twice-yearly injectable treatment for schizophrenia in adults

EXPERT REVIEW OF NEUROTHERAPEUTICS

IF3.4

2024-03-063

PRE

Enhancing Transparency in Defining Studied Drugs: The Open-Source Living DiAna Dictionary for Standardizing Drug Names in the FAERS

IF3.8

2024-01-047

OAAI

Barriers to the use of three-month Paliperidone Palmitate formulation: a study from an Italian real-world setting

EXPERT REVIEW OF NEUROTHERAPEUTICS

IF3.4

2023-09-302

PRE

The potential effect of metformin on cognitive and other symptom dimensions in patients with schizophrenia and antipsychotic-induced weight gain: a systematic review, meta-analysis, and meta-regression

FRONTIERS IN PSYCHIATRY

IF3.2

2023-07-1212

OAAI

A novel approach for pharmacological substantiation of safety signals using plasma concentrations of medication and administrative/healthcare databases: A case study using Danish registries for an FDA warning on lamotrigine

PHARMACOLOGICAL RESEARCH

IF10.5

2023-07-011

OAAI

Ubrogepant and rimegepant: signal detection using spontaneous reports of adverse events from the Food and Drug Administration Adverse Event Reporting System

EXPERT OPINION ON DRUG SAFETY

IF3.1

2023-06-128

PRE